Faron Pharmaceuticals Ltd: Holding(s) in Company

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FIN-FSA)

1. Identity of the issuer:
Faron Pharmaceuticals Oy

2. Reason for the notification (please tick the appropriate box or boxes):

☐ An acquisition or disposal of shares or voting rights
☒ An acquisition or disposal of financial instruments
☐ An event changing the breakdown of shares or voting rights
☐ Other (please specify): Click here to enter text.

3. Details of person subject to the notification obligation:

Name:
Bank of America Corporation

City and country of residence:
Wilmington, DE, United States of America

4. Full name of shareholder(s) (if different from 3.):
–

5. Date on which the threshold was crossed or reached:
4.6.2026

6. Total positions of person(s) subject to the notification obligation:

% of shares and voting rights
(total of 7.A)

% of shares and voting rights through financial instruments
(total of 7.B)

Total of both in % (7.A + 7.B)

Total number of shares and voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

0.11

10.46

10.57

206,411,888

Position of previous notification (if applicable)

0.10

9.36

9.46

7. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Shares and voting rights

Class/type of
shares
ISIN code (if possible)

Number of shares and voting rights

% of shares and voting rights

Direct
(SMA 9:5)

Indirect
(SMA 9:6 and 9:7)

Direct
(SMA 9:5)

Indirect
(SMA 9:6 and 9:7)

FI4000153309

0

235,532

0

0.11

–

–

–

–

–

–

–

–

–

–

SUBTOTAL A

235,532

0.11

B: Financial Instruments according to SMA 9:6a

Type of financial instrument

Expiration
date

Exercise/
Conversion Period

Physical or cash settlement

Number of shares and voting rights

% of shares and voting rights

Rights of Use

n/a

n/a

n/a

21,333,422

10.34

Swaps

15/10/2027

n/a

Cash

243,327

0.12

–

–

–

–

–

–

SUBTOTAL B

21,576,749

10.46

8. Information in relation to the person subject to the notification obligation (please tick the applicable box):

☐ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

☒ Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name

% of shares and voting rights

% of shares and voting rights through financial instruments

Total of both

Bank of America Corporation

NB Holdings Corporation

BofAML Jersey Holdings Limited

BofAML EMEA Holdings 2 Limited

ML UK Capital Holdings Limited

Merrill Lynch International

Bank of America Corporation

NB Holdings Corporation

BAC North America Holding Company

Bank of America, National Association

Bank of America Corporation

NB Holdings Corporation

Bofa Securities, Inc

10.34%

10.34%

9. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of

10. Additional information: